Company: PFSA
Filing Date: 2025-05-13
Form Type: S-4/A
Source: 0001213900-25-042224
Chunk: 349

Company: Profusa, Inc.
Filing Date: 2025-05-13
Form: S-4/A
Chunk 349
---
                                                         |     |             |   4,660,000 |   |     |            |   4,660,000 |   |
| Profusa bridge notes(9)                                                                    |     |             |   4,285,012 |   |     |            |   4,285,012 |   |
| Northview working capital loan(10)                                                         |     |             |     863,908 |   |     |            |     863,908 |   |
| PIPE Subscription(7)                                                                       |     |             |   1,000,000 |   |     |            |   1,000,000 |   |
| As adjusted NorthView’s shares outstanding                                                 |     |             |  33,002,012 |   |     |            |  32,949,853 |   |

________________ (1)Calculated as NorthView’s net tangible book value as of December 31, 2024, as adjusted to reflect the proforma adjustments presented in the Unaudited Pro Forma Condensed Combined Balance Sheet. (2)The calculation of adjusted net tangible book value per share excludes shares underlying NorthView warrants and NorthView Private Placement Warrants, as the exercise price of $11.50 per share. and the exercise of these warrants is not considered probable as of the Business Combination date. Should these warrants be exercised in the future, they would result in additional dilution to NorthView shareholders, as presented below. (3)Includes Sponsor and Representative shares in NorthView and has been reduced by the 710,220 Sponsor shares allocated to the senior secured convertible note holders. (4)Includes 7,152,683shares expected to be issued to existing Profusa common and preferred shareholders, 7,966,963shares expected to be issued to the holders of Profusa’s junior convertible notes and senior convertible notes, and 380,354shares reserved for Profusa option holders under each redemption scenario. (5)Includes 1,897,500shares issuable pursuant to outstanding NorthView Rights. (6)Represents $1,575,000 of transaction costs being paid in shares of New Profusa Common Stock at $10 per share. (7)Assumes 1,000,000shares issuable upon conversion of the $10 million first tranche of the PIPE Investor convertible note facility ($22.22 million total) at $10 per share.

178

(8)Senior secured convertible note which includes 710,